News
Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...
9d
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...
TipRanks on MSN5d
Rein Therapeutics Gains Approval for Phase 2 Trial
Rein Therapeutics ( ($RNTX) ) has provided an announcement. On August 19, 2025, Rein Therapeutics announced that the UK Medicines and Healthcare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback